144 related articles for article (PubMed ID: 37566020)
21. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS
PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
[TBL] [Abstract][Full Text] [Related]
22. Roles of genetic variants in the PI3K/PTEN pathways in susceptibility to colorectal carcinoma and clinical outcomes treated with FOLFOX regimen.
Lin L; Zhang Z; Zhang W; Wang L; Wang J
Int J Clin Exp Pathol; 2015; 8(10):13314-22. PubMed ID: 26722535
[TBL] [Abstract][Full Text] [Related]
23. Correlation of miR-31 and miR-373 expression with KRAS mutations and its impact on prognosis in colorectal cancer.
Ashoori H; Kamian S; Vahidian F; Ghamarchehreh ME
J Egypt Natl Canc Inst; 2022 Aug; 34(1):35. PubMed ID: 35989410
[TBL] [Abstract][Full Text] [Related]
24. Integrating
Ntavatzikos A; Spathis A; Patapis P; Machairas N; Peros G; Konstantoudakis S; Leventakou D; Panayiotides IG; Karakitsos P; Koumarianou A
World J Gastroenterol; 2017 Aug; 23(32):5913-5924. PubMed ID: 28932083
[TBL] [Abstract][Full Text] [Related]
25. Pri-miR-34b/c rs4938723 Polymorphism is Associated with Decreased Risk and Better Prognosis for Colorectal Cancer Patients.
Kassim SA; Yang X; Abbas M; Wu S; Faran Ashraf Baig MM; Meng QT; Zhang C; Li X; Chen R
Arch Med Res; 2019 Feb; 50(2):55-62. PubMed ID: 31349954
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China.
Chang XN; Shang FM; Jiang HY; Chen C; Zhao ZY; Deng SH; Fan J; Dong XC; Yang M; Li Y; Cai KL; Liu L; Liu HL; Nie X
Curr Med Sci; 2021 Feb; 41(1):118-126. PubMed ID: 33582915
[TBL] [Abstract][Full Text] [Related]
27. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.
Ye JX; Liu Y; Qin Y; Zhong HH; Yi WN; Shi XY
World J Gastroenterol; 2015 Feb; 21(5):1595-605. PubMed ID: 25663779
[TBL] [Abstract][Full Text] [Related]
28. Association of single nucleotide polymorphisms in the coding region of Bcl-2 with the occurrence and prognosis of colorectal cancer: A case-control study.
Huang B; Liu X; Sun C; Wang L; Yang L
Cancer Biomark; 2017; 18(4):433-439. PubMed ID: 28106544
[TBL] [Abstract][Full Text] [Related]
29. A genetic variant in miR-146a modifies colorectal cancer susceptibility in a Chinese population.
Ma L; Zhu L; Gu D; Chu H; Tong N; Chen J; Zhang Z; Wang M
Arch Toxicol; 2013 May; 87(5):825-33. PubMed ID: 23306950
[TBL] [Abstract][Full Text] [Related]
30. Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.
Yari A; Samoudi A; Afzali A; Karam ZM; Karimaldini NK; Abadi MFS; Ziasistani M; Zangouey MR; Dabiri S
J Gastrointest Cancer; 2021 Jun; 52(2):557-568. PubMed ID: 32495109
[TBL] [Abstract][Full Text] [Related]
31. The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.
Gutiérrez-Malacatt H; Ayala-Sanchez M; Aquino-Ortega X; Dominguez-Rodriguez J; Martinez-Tovar A; Olarte-Carrillo I; Martinez-Hernandez A; C CC; Orozco L; Cordova EJ
Asian Pac J Cancer Prev; 2016; 17(4):2265-70. PubMed ID: 27221928
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
34. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.
Hu H; Zhang L; Teng G; Wu Y; Chen Y
Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738
[TBL] [Abstract][Full Text] [Related]
35. The association of a single-nucleotide variant in the microRNA-146a with advanced colorectal cancer prognosis.
Santos JSD; Zunta GL; Negrini AB; Ribeiro MSG; Martinez CAR; Ribeiro ML; Lourenço GJ; Ortega MM
Tumour Biol; 2020 May; 42(5):1010428320923856. PubMed ID: 32438863
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.
Messaritakis I; Stogiannitsi M; Koulouridi A; Sfakianaki M; Voutsina A; Sotiriou A; Athanasakis E; Xynos E; Mavroudis D; Tzardi M; Souglakos J
PLoS One; 2018; 13(6):e0197327. PubMed ID: 29883450
[TBL] [Abstract][Full Text] [Related]
37. Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.
Kjersem JB; Ikdahl T; Guren T; Skovlund E; Sorbye H; Hamfjord J; Pfeiffer P; Glimelius B; Kersten C; Solvang H; Tveit KM; Kure EH
BMC Cancer; 2012 Nov; 12():534. PubMed ID: 23167843
[TBL] [Abstract][Full Text] [Related]
38. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.
He SY; Li YC; Wang Y; Peng HL; Zhou CL; Zhang CM; Chen SL; Yin JF; Lin M
World J Gastroenterol; 2022 Jul; 28(25):2920-2936. PubMed ID: 35978873
[TBL] [Abstract][Full Text] [Related]
39. Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer.
Eilertsen IA; Sveen A; Strømme JM; Skotheim RI; Nesbakken A; Lothe RA
Int J Cancer; 2019 Feb; 144(4):841-847. PubMed ID: 30121958
[TBL] [Abstract][Full Text] [Related]
40. Association of the rs1966265 and rs351855
Carrillo-Dávila IA; Garibaldi-Ríos AF; Figuera LE; Gómez-Meda BC; Zúñiga-González GM; Puebla-Pérez AM; García-Verdín PM; Castro-García PB; Gutiérrez-Hurtado IA; Torres-Mendoza BM; Gallegos-Arreola MP
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
